Literature DB >> 8641505

The impact of preoperative gonadotropin-releasing hormone agonist treatment on laparoscopic excision of ovarian endometriotic cysts.

L Muzii1, R Marana, P Caruana, S Mancuso.   

Abstract

OBJECTIVE: To compare surgical performance and recurrence rates in patients submitted to laparoscopy for endometrioma excision following GnRH agonist (GnRH-a) treatment versus no preoperative medical treatment.
DESIGN: Controlled clinical study.
SETTING: A tertiary care university hospital. PATIENTS: Twenty patients with unilateral endometriomas underwent operative laparoscopy after 3-month GnRH-a treatment, whereas 21 patients underwent laparoscopic excision of endometriomas without preoperative medical treatment.
INTERVENTIONS: Operative laparoscopy was performed with the stripping technique using a four-puncture approach. MAIN OUTCOME MEASURE: A blinded videotape review was undertaken to evaluate the duration and complexity of the different phases of surgery. Recurrence rates were evaluated at 1-year follow-up ultrasonography.
RESULTS: No significant difference was found between the two groups in total operative time, cyst excision time, time needed for cyst capsule stripping and coagulation of ovarian parenchyma, and the complexity of the latter phases; recurrence rates also were comparable.
CONCLUSION: Preoperative GnRH-a treatment for endometriomas does not seem to offer any advantage in terms of subsequent surgical performance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641505     DOI: 10.1016/s0015-0282(16)58346-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  National German Guideline (S2k): Guideline for the Diagnosis and Treatment of Endometriosis: Long Version - AWMF Registry No. 015-045.

Authors:  U Ulrich; O Buchweitz; R Greb; J Keckstein; I von Leffern; P Oppelt; S P Renner; M Sillem; W Stummvoll; R-L De Wilde; K-W Schweppe
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-12       Impact factor: 2.915

2.  Interdisciplinary S2k Guidelines for the Diagnosis and Treatment of Endometriosis: Short Version - AWMF Registry No. 015-045, August 2013.

Authors:  U Ulrich; O Buchweitz; R Greb; J Keckstein; I von Leffern; P Oppelt; S P Renner; M Sillem; W Stummvoll; K-W Schweppe
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

3.  Endometriosis for the colorectal surgeon.

Authors:  Katrina Slaughter; Rajiv B Gala
Journal:  Clin Colon Rectal Surg       Date:  2010-06

4.  Feasibility of Laparoscopic Hysterectomy in Stage IV Pelvic Endometriosis: Our Technique and Outcomes.

Authors:  Devi Balasubramaniam; Kavitha Yogini Duraisamy; Palanivelu Chinnusamy; Swathi Nethaji; Sangeetha Karunanithi
Journal:  J Midlife Health       Date:  2020-05-04

Review 5.  Pre and post operative medical therapy for endometriosis surgery.

Authors:  C Yap; S Furness; C Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 6.  Recurrence of endometriosis; risk factors, mechanisms and biomarkers; review of the literature.

Authors:  Ilker Selçuk; Gürkan Bozdağ
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-06-01

Review 7.  Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility.

Authors:  Matthew Latham Macer; Hugh S Taylor
Journal:  Obstet Gynecol Clin North Am       Date:  2012-12       Impact factor: 2.844

8.  Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial.

Authors:  Ayako Muraoka; Satoko Osuka; Atsushi Yabuki; Masato Yoshihara; Hideaki Tanaka; Reina Sonehara; Natsuki Miyake; Mayuko Murakami; Sayako Yoshita; Natsuki Nakanishi; Tomoko Nakamura; Maki Goto; Akira Iwase; Hiroaki Kajiyama
Journal:  Reprod Biol Endocrinol       Date:  2021-12-06       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.